跳至主要内容
临床试验/JPRN-UMIN000034893
JPRN-UMIN000034893已完成未知

Analysis of refractory ascites components of patients with ovarian cancer, fallopian tube cancer and peritoneal cancer, and examination of influence by Cell-free and Concentrated Ascites Reinfusion Therapy (CART) - Analysis of ascites components, and examination of influence by CART

Iwate Medical University0 个研究点目标入组 15 人开始时间: 2018年11月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with fever and suspected of detecting endotoxin 2. Highly immunocompromised patients such as bone marrow transplantation 3. Patients with severe heart failure, renal failure, liver failure combined 4. Patients complicated with bacterial peritonitis 5. Serious liver disorder patients with overt jaundice 6. Patients used Bevacizumab within 6 weeks 7. Patients using steroids for mitigation purposes 8. Patients participating in other trials and clinical studies 9. Patients who are determined to be disqualified by a principal investigator

研究者

相似试验